Navigation Links
AquaStar Holdings, Inc. Subsidiary Appoints Former Beckman Coulter Executive as Vice President of Operations

SANTA ANA, Calif., June 3, 2011 /PRNewswire/ -- AquaStar Holdings, Inc. (Pink Sheets: RPPR) is pleased to announce that the Company's wholly-owned subsidiary, SUTIMCo, Inc., has retained the services of Mr. Ed Ellsworth as Vice President of Business Development.  Mr. Ellsworth will assist with the development and positioning of the numerous University conceived technologies that SUTIMCo manages. Mr. Ellsworth, who comes to SUTIMCo straight from Beckman Coulter (NYSE: BEC), will be immediately tasked with the development of the Capwave Enzyme-Linked Immuno-Sorbent Assay (ELISA) platform technology.

Mr. Ellsworth brings more than 20 years experience in the diagnostic and life science industry with a focus on commercializing and advancing technology across the life science continuum. Mr. Ellsworth has numerous years with Beckman Coulter, a leader in the Biotechnology Industry with over $3.7 billion in revenue for 2010, where most recently he was responsible for operational marketing and business management of the immunochemistry, hematology, chemistry and rapid diagnostic testing products for the channel business. In addition, Mr. Ellsworth directed the distributor partnership corporate accounts group delivering over $100 million in revenue.

"SUTIMCo is in the forefront of bringing exciting new technologies to market.  I'm delighted to be on the team and I look forward to working with SUTIMCo management," stated Ed Ellsworth, Vice President of Business Development of SUTIMCo, Inc.

"Ed's appointment further deepens our understanding of the diagnostic and life science industry and will be a tremendous contribution as we develop our client companies," stated Malcolm Lennie, President of AquaStar Holdings, Inc. "He comes with extensive, real-life understanding of technology commercialization that will be a valuable asset to the Company."

For more information on SUTIMCo, its portfolio companies, and University partners, please visit;

About AquaStar Holdings, Inc.:

AquaStar Holdings, Inc. is a holding company, which utilizes a unique and established platform to launch new technology enterprises based on world-class university research discoveries. AquaStar Holdings, through its wholly owned subsidiary SUTIMCo, Inc., provides experienced management to early stage companies, reducing risk and assuring the know-how in launching and growing a new company. In addition to this skilled management team, AquaStar Holdings can avail itself of the encyclopedic, informal knowledge of the inventor, his experience and his research team.

Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. The Company is a development stage company who continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results

Investor Relations

SOURCE AquaStar Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. AquaStar Holdings, Inc.s Client Receives U.S. Patent 7,708,944 for Portable Capillary Sensor Technology
2. China Pharma Holdings, Inc. Will Attend the Susquehanna Financial Group, LLP (SIG) Beijing Management Summit
3. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
4. China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40%
5. China Pharma Holdings, Inc. Appoints The Ruth Group
6. BioAuthorize Holdings, Inc. Names New Directors and Executive and Unveils Modification to Its Voice Biometric Authentication Service
7. China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences
8. China Pharma Holdings, Inc. Receives SFDA Production Approval for Tiopronin Enteric-Coated Capsules
9. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
10. JAG Media Holdings, Inc. Announces Letter of Intent for the Acquisition of CardioGenics Inc. by a Wholly-Owned Subsidiary of JAG Media
11. EFT BioTech Holdings, Inc.s Subsidiary Receives First Permit to Cross Taiwan Strait
Post Your Comments:
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... research firm Parks Associates announced today that Tom Kerber ... Annual Meeting , October 11 in Scottsdale, Arizona . ... how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the ...
(Date:10/9/2017)... ... October 09, 2017 , ... The award-winning American Farmer television series will feature ... Farmer airs Tuesdays at 8:30aET on RFD-TV. , With global population estimates nearing ... how to continue to feed a growing nation. At the same time, many of ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):